33 results
8-K
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
a fixed consulting fee equal to $10,000 per month, as well as a transaction bonus in the amount of $150,000.
Additionally, as of the Effective Date
DEFA14A
ELYM
Eliem Therapeutics Inc
12 Jun 24
Additional proxy soliciting materials
4:42pm
employment, Dr. Brennan will be paid a base salary of $650,000 per year. Dr. Brennan will also be eligible to receive an annual discretionary bonus of up … base salary and a prorated amount of her target annual discretionary bonus opportunity for the year in which the termination of her employment occurs
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
to earn an annual discretionary bonus (the “Annual Bonus”) with an annual target of fifty-five percent (55%) of your earned salary during … the applicable bonus year (the “Target Amount”). The amount of the Annual Bonus will be determined in the sole discretion of the Board, or a committee thereof
8-K
ELYM
Eliem Therapeutics Inc
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
salary of $650,000 per year. Dr. Brennan will also be eligible to receive an annual discretionary bonus of up to 55.0% of her annualized base salary … target annual discretionary bonus opportunity for the year in which the termination of her employment occurs, (2) make payments for the continuation
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
. These interests with respect to Tenet’s directors and executive officers may include, among others, transaction bonus payments, discretionary annual performance … a base salary of $450,000. Dr. Thomas will be eligible to receive a discretionary annual performance bonus targeted at 50% of this annual base salary
PREM14A
fjpir88hv h4s7
17 May 24
Preliminary proxy related to merger
4:36pm
DEFA14A
gcsoj
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-2.1
ujutnrdi23
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
0jdtpnhq3mc
20 Dec 22
Departure of Directors or Certain Officers
4:02pm
DEF 14A
68elysyrix re621tz7
8 Apr 22
Definitive proxy
4:20pm
10-K
69vsrzhq3
7 Mar 22
Annual report
4:03pm
8-K
33vjnop88xtt0dubwe
31 Jan 22
Departure of Directors or Certain Officers
5:16pm
424B4
luvjl5
11 Aug 21
Prospectus supplement with pricing info
5:05pm